Trial intelligence / Profile preview

Nasal tobramycin and colistin pharmacokinetics in adults with cystic fibrosis

NL-OMON38737Not yet recruiting

Start
Apr 2013
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Open-label, single-arm trial of tobramycin and colistin in cystic fibrosis (CF) and Pseudomonal infection, sponsored by none. Primary endpoints: Area under the concentration-time curve, Time to maximum concentration and 3 more. Planned start Apr 2013; status: not yet recruiting.

02

Drugs

tobramycincolistin
03

Conditions

cystic fibrosis (CF)Pseudomonal infection

Beyond the preview

Go deeper on NL-OMON38737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call